New York — New York, New York

New York is a clinical research site located in New York, New York, United States.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

New York has participated in 33 clinical trials with 6 currently active.

Therapeutic areas: Hepatitis C, Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer.

Sponsors: Vertex Pharmaceuticals Incorporated, Finch Research and Development LLC., Corcept Therapeutics.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York?

New York has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York conducted?

New York has 33 clinical trials on record, with 6 currently active. Their work covers Hepatitis C, Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer.

Is New York accredited by Crixeo Health?

Yes — New York holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.